Amgen will hold a webcast on October 24, 2026, during the European Society of Medical Oncology Congress (ESMO) to discuss its oncology portfolio and present selected data. The event will feature senior executives including Murdo Gordon and Jean-Charles Soria and will be accessible to investors, media, and the public via Amgen's website. This webcast highlights Amgen's ongoing commitment to innovation in cancer treatment and provides insights into its latest research developments. The webcast will be archived for replay for at least 30 days after the event.
Amgen's stock price on Pluang is currently USD 439.94 as of October 21, 2026, showing a 3.53% increase in the last day. The company holds a significant market cap of $229.74 billion, indicating its strong presence in the health sector. Despite the positive price movement, most Pluang users are selling Amgen shares, with 97% of order activity being sell orders as of the same date.
Eli Lilly's stock rose 4% following a positive recommendation from the European Medicines Agency for its oral obesity pill, Foundayo, which is now close to final approval in the EU. This pill offers dosing flexibility and treats both weight managemen...
Amgen and AstraZeneca announced positive Phase 3 CROSSING trial results for TEZSPIRE (tezepelumab-ekko), demonstrating significant and lasting improvements in patients with eosinophilic esophagitis (EoE). The drug achieved histologic remission in abo...
